These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 25656249)

  • 1. Methotrexate for maintaining remission in paediatric Crohn's patients with prior failure or intolerance to thiopurines: a multicenter cohort study.
    Haisma SM; Lijftogt T; Kindermann A; Damen G; de Ridder L; Escher JC; Mearin ML; de Meij T; Hendriks D; George E; Hummel T; Norbruis O; van Rheenen P
    J Crohns Colitis; 2015 Apr; 9(4):305-11. PubMed ID: 25656249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis.
    Kopylov U; Katsanos KH; van der Woude CJ; Karmiris K; Hernandez V; Odes S; Papamichael K; Koutroubakis IE; Bojic D; Kaimakliotis I; Fiorino G; Papageorgiou N; Pineda JR; Strongili K; Sanroman L; Mantzaris GJ; Jojic N; Paspatis G; Christodoulou DK; Ben-Horin S; Tsianos EV
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):802-6. PubMed ID: 26894634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B; Lerner A; Shapiro R; Broide E; Levine A; Fradkin A; Bujanover Y
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease.
    Hojsak I; Mišak Z; Jadrešin O; Močić Pavić A; Kolaček S
    Scand J Gastroenterol; 2015; 50(10):1208-13. PubMed ID: 25877164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of methotrexate therapy for refractory Crohn's disease: a large single-centre experience.
    Suares NC; Hamlin PJ; Greer DP; Warren L; Clark T; Ford AC
    Aliment Pharmacol Ther; 2012 Jan; 35(2):284-91. PubMed ID: 22112005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease.
    Turner D; Grossman AB; Rosh J; Kugathasan S; Gilman AR; Baldassano R; Griffiths AM
    Am J Gastroenterol; 2007 Dec; 102(12):2804-12; quiz 2803, 2813. PubMed ID: 18042110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of oral methotrexate in paediatric Crohn's disease: a multicentre propensity score study.
    Turner D; Doveh E; Cohen A; Wilson ML; Grossman AB; Rosh JR; Lu Y; Bousvaros A; Deslandres C; Noble A; Baldassano RN; Levine A; Lerner A; Wilson DC; Griffiths AM
    Gut; 2015 Dec; 64(12):1898-904. PubMed ID: 25416066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study.
    Uhlen S; Belbouab R; Narebski K; Goulet O; Schmitz J; Cézard JP; Turck D; Ruemmele FM
    Inflamm Bowel Dis; 2006 Nov; 12(11):1053-7. PubMed ID: 17075346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the risk of clinical failure between thiopurine and methotrexate in bio-naïve patients with Crohn's disease: a Korean nationwide population-based study.
    Jun YK; Ji E; Yang HR; Choi Y; Shin CM; Park YS; Kim N; Lee DH; Yoon H
    Therap Adv Gastroenterol; 2024; 17():17562848241248321. PubMed ID: 38741927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration.
    Nathan DM; Iser JH; Gibson PR
    J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
    Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A
    BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective cohort study of methotrexate use in the treatment of pediatric Crohn's disease.
    Sunseri W; Hyams JS; Lerer T; Mack DR; Griffiths AM; Otley AR; Rosh JR; Carvalho R; Grossman AB; Cabrera J; Pfefferkorn MD; Rick J; Leleiko NS; Hitch MC; Oliva-Hemker M; Saeed SA; Kappelman M; Markowitz J; Keljo DJ;
    Inflamm Bowel Dis; 2014 Aug; 20(8):1341-5. PubMed ID: 24983976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.
    Harris RE; Aloi M; de Ridder L; Croft NM; Koletzko S; Levine A; Turner D; Veereman G; Neyt M; Bigot L; Ruemmele FM; Russell RK;
    BMJ Open; 2020 Jul; 10(7):e034892. PubMed ID: 32611737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of thiopurines can recapture response in patients with Crohn's disease who have lost response to anti-tumor necrosis factor monotherapy.
    Ong DE; Kamm MA; Hartono JL; Lust M
    J Gastroenterol Hepatol; 2013 Oct; 28(10):1595-9. PubMed ID: 23662928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-center experience with methotrexate after thiopurine therapy in pediatric Crohn disease.
    Boyle B; Mackner L; Ross C; Moses J; Kumar S; Crandall W
    J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):714-7. PubMed ID: 20706154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained clinical benefit and tolerability of methotrexate monotherapy after thiopurine therapy in patients with Crohn's disease.
    Seinen ML; Ponsioen CY; de Boer NK; Oldenburg B; Bouma G; Mulder CJ; van Bodegraven AA
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):667-72. PubMed ID: 23333660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.
    Domènech E; Mañosa M; Navarro M; Masnou H; Garcia-Planella E; Zabana Y; Cabré E; Gassull MA
    J Clin Gastroenterol; 2008 Apr; 42(4):395-9. PubMed ID: 18277899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of methotrexate in refractory Crohn's disease: the Edinburgh experience.
    Din S; Dahele A; Fennel J; Aitken S; Shand AG; Arnott ID; Satsangi J
    Inflamm Bowel Dis; 2008 Jun; 14(6):756-62. PubMed ID: 18275071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic role of methotrexate in pediatric Crohn's disease.
    Djurić Z; Šaranac L; Budić I; Pavlović V; Djordjević J
    Bosn J Basic Med Sci; 2018 Aug; 18(3):211-216. PubMed ID: 29338679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance and efficacy of azathioprine in pediatric Crohn's disease.
    Riello L; Talbotec C; Garnier-Lengliné H; Pigneur B; Svahn J; Canioni D; Goulet O; Schmitz J; Ruemmele FM
    Inflamm Bowel Dis; 2011 Oct; 17(10):2138-43. PubMed ID: 21910176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.